BRIEF-Teva Pharmaceutical receives complete response letter for SD-809

May 31 Teva Pharmaceutical Industries Ltd

* FDA has asked Teva to examine blood levels of certain
metabolites

* No new clinical trials have been requested

* Teva receives complete response letter for NDA for sd-809
for the treatment of chorea associated with Huntington disease

* Teva Pharmaceutical Says “Teva Will Continue To Work
Closely With FDA To Bring SD-809 to market as quickly as
possible”

* Plan to submit response to complete response letter in q3
2016

* Programs for development of sd-809 for treatment of
patients with Tardive Dyskinesia, Tourette Syndrome ongoing

Source text for Eikon:
Further company coverage:

(Bengaluru Newsroom: +1-646-223-8780)

This article is automatically posted by WP-AutoPost Plugin

Source URL:http://www.reuters.com/article/idUSFWN18S097

News

BRIEF-Moody's says Euro Area's economic recovery supports stable 2018 outlook

January 15, 2018 mmayha 0

Jan 15 (Reuters) – Moody‘s: * MOODY‘S SAYS EURO AREA‘S ECONOMIC RECOVERY SUPPORTS STABLE 2018 OUTLOOK, DESPITE PATCHY STRUCTURAL REFORM PROGRESS‍​ * MOODY‘S SAYS FORECASTS THAT EURO AREA GROWTH WILL AVERAGE 2.0 PERCENT IN 2018, […]

News

RPT-Germany to include yuan in FX reserves – c.banker

January 15, 2018 mmayha 0

(Repeats to more subscribers) HONG KONG, Jan 15 (Reuters) – Germany’s central bank has decided to include China’s currency, the yuan, in its foreign exchange reserves, Bundesbank board member Andreas Dombret said in Hong Kong […]

News

Singapore files more charges against Shell oil theft suspects

January 15, 2018 mmayha 0

SINGAPORE (Reuters) – A Singapore court on Monday filed additional charges against nine men accused in a large-scale oil theft at Shell’s biggest refinery, the latest development in an extensive investigation in the city-state. The […]

Be the first to comment

Leave a Reply